Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta] (2022)
- Authors:
- Autor USP: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidade: FM
- DOI: 10.1097/MPA.0000000000002040
- Subjects: MICRORNAS; DIABETES MELLITUS; BIOMARCADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PEIXOTO, Renata D'Alpino et al. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]. Pancreas. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/MPA.0000000000002040. Acesso em: 25 fev. 2026. , 2022 -
APA
Peixoto, R. D. 'A., Donnarumma, C. D. C., Matheus, L. H. G., Santos, A. S., Santos-Bezerra, D. P., Matos, M. R. de, et al. (2022). Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]. Pancreas. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/MPA.0000000000002040 -
NLM
Peixoto RD'A, Donnarumma CDC, Matheus LHG, Santos AS, Santos-Bezerra DP, Matos MR de, Neves JAJ, Camacho CP, Giannella MLCC. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta] [Internet]. Pancreas. 2022 ; 51( 5): E76-E77.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1097/MPA.0000000000002040 -
Vancouver
Peixoto RD'A, Donnarumma CDC, Matheus LHG, Santos AS, Santos-Bezerra DP, Matos MR de, Neves JAJ, Camacho CP, Giannella MLCC. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta] [Internet]. Pancreas. 2022 ; 51( 5): E76-E77.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1097/MPA.0000000000002040 - Expression analysis of proto-oncogene ret in patients with primary hyperparathyroidism: comparison between hyperplasia, adenoma and carcinoma
- Continuous glucose monitoring system: dawn period calibration does not change accuracy
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
- Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Association between tumor GHSR-IA mRNA expression and in vivo response to GHRP-6 in patients with ACTH-dependent Cushing`s syndrome
- Visceral adiposity syndrome
- Polymorphisms in the gene encoding glucose transporter Glut-1 (SLC2A1) and renal disease in type 1 diabetic patients
- 3111T/clock gene polymorphism is associated with metabolic changes in Brazilian obese children and adolescents
- Celiac crisis in an adult type 1 diabetes mellitus patient: a rare manifestation of celiac disease
- Association between the 308G/A TNF promoter variant insulin resistance and hypertension in obese children
Informações sobre o DOI: 10.1097/MPA.0000000000002040 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
